Vivotek Inc. (3454.TW)
TWD 112.5
(-1.75%)
TWD 112.5
(-1.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.16 Billion | 9.94 Billion | 5.45 Billion | 5.54 Billion | 6.57 Billion | 5.23 Billion |
| Cost of Revenue | 6.82 Billion | 7.36 Billion | 3.83 Billion | 3.67 Billion | 4.53 Billion | 3.43 Billion |
| Gross Profit | 2.34 Billion | 2.58 Billion | 1.61 Billion | 1.86 Billion | 2.03 Billion | 1.8 Billion |
| Operating Expenses | 1.91 Billion | 1.8 Billion | 1.51 Billion | 1.6 Billion | 1.73 Billion | 1.52 Billion |
| Selling, General and Administrative Expenses | 1.21 Billion | 1.07 Billion | 870.05 Million | 873.29 Million | 1 Billion | 873.04 Million |
| Research and Development Expenses | 721.5 Million | 721.53 Million | 645.62 Million | 730.05 Million | 735.76 Million | 647.68 Million |
| Other Expenses | - | 53.84 Million | 114.26 Million | 15.48 Million | 14.95 Million | 46.12 Million |
| Cost and Expenses | 8.73 Billion | 9.16 Billion | 5.35 Billion | 5.27 Billion | 6.27 Billion | 4.95 Billion |
| Operating Income | 422.72 Million | 845.69 Million | 214.38 Million | 284.42 Million | 318.49 Million | 279.57 Million |
| Interest Expense | 16.41 Million | 9.43 Million | 8.41 Million | 7.59 Million | 9.62 Million | 6.47 Million |
| Income Tax Expense | 64.16 Million | 99.41 Million | -4.73 Million | 55.32 Million | 66.99 Million | 52.83 Million |
| Earnings before Tax | 575.05 Million | 831.6 Million | 200.72 Million | 276.83 Million | 308.86 Million | 318.99 Million |
| Net Income | 489.27 Million | 702.19 Million | 188.13 Million | 250.82 Million | 274.9 Million | 329.57 Million |
| Earnings Per Share Basic | 5.65 | 8.11 | 2.17 | 2.90 | 3.19 | 3.83 |
| Earnings Per Share Diluted | 5.62 | 8.06 | 2.16 | 2.87 | 3.16 | 3.78 |
| Weighted Average Shares Outstanding | 86.56 Million | 86.56 Million | 86.56 Million | 86.37 Million | 86.23 Million | 86.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 87.03 Million | 87.1 Million | 86.91 Million | 87.38 Million | 86.86 Million | 87.14 Million |
| Gross Margin | 0.26 | 0.26 | 0.30 | 0.34 | 0.31 | 0.34 |
| EBIT Margin | 0.08 | 0.10 | 0.07 | 0.09 | 0.08 | 0.09 |
| Profit Margin | 0.05 | 0.07 | 0.03 | 0.05 | 0.04 | 0.06 |
| EBITDA | 771.22 Million | 1.01 Billion | 402.8 Million | 512.46 Million | 543.24 Million | 452.3 Million |
| Earnings Before Tax Margin | 0.05 | 0.09 | 0.04 | 0.05 | 0.05 | 0.05 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.89 Billion | 1.67 Billion | 1.58 Billion | 1.85 Billion | 9.16 Billion | 2.31 Billion |
| Cost of Revenue | 1.25 Billion | 1.15 Billion | 1.11 Billion | 1.27 Billion | 6.82 Billion | 1.66 Billion |
| Gross Profit | 636.21 Million | 528.8 Million | 467.98 Million | 580.84 Million | 2.34 Billion | 650.74 Million |
| Operating Expenses | 517.68 Million | 512.89 Million | 486.36 Million | 495.73 Million | 1.91 Billion | 487.16 Million |
| Selling, General and Administrative Expenses | 328.25 Million | 331.92 Million | 310.82 Million | 319.35 Million | - | 302.71 Million |
| Research and Development Expenses | 189.43 Million | 180.96 Million | 175.53 Million | 176.38 Million | - | 184.44 Million |
| Other Expenses | - | 17.89 Million | 22.76 Million | 19.5 Million | 151.58 Million | 25.75 Million |
| Cost and Expenses | 1.77 Billion | 1.66 Billion | 1.6 Billion | 1.77 Billion | 8.73 Billion | 2.15 Billion |
| Operating Income | 118.52 Million | 15.91 Million | -18.38 Million | 85.11 Million | 422.72 Million | 193.71 Million |
| Interest Expense | 5.33 Million | 5.59 Million | 6.32 Million | 7.51 Million | 16.41 Million | 4.44 Million |
| Income Tax Expense | 18.66 Million | 3.8 Million | 257 Thousand | 13.54 Million | 64.16 Million | 26.17 Million |
| Earnings before Tax | 120.1 Million | 35.27 Million | 4.23 Million | 103.5 Million | 575.05 Million | 181.15 Million |
| Net Income | 95.45 Million | 26.04 Million | 1.94 Million | 84.08 Million | 489.27 Million | 145.69 Million |
| Earnings Per Share Basic | 1.11 | 0.30 | 0.02 | 0.97 | - | 1.68 |
| Earnings Per Share Diluted | 1.10 | 0.30 | 0.02 | 0.96 | - | 1.68 |
| Weighted Average Shares Outstanding | 85.99 Million | 86.56 Million | 86.56 Million | 86.56 Million | 86.56 Million | 86.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 86.77 Million | 86.59 Million | 86.84 Million | 87.17 Million | 87.03 Million | 86.92 Million |
| Gross Margin | 0.34 | 0.31 | 0.30 | 0.31 | 0.26 | 0.28 |
| EBIT Margin | 0.09 | 0.03 | 0.01 | 0.07 | - | 0.10 |
| Profit Margin | 0.05 | 0.02 | 0.00 | 0.05 | 0.05 | 0.06 |
| EBITDA | 164.56 Million | 55.91 Million | 18.28 Million | 129.53 Million | - | 240.7 Million |
| Earnings Before Tax Margin | 0.06 | 0.01 | -0.01 | 0.05 | 0.05 | 0.08 |
ROAOF
002082
STARHEALTH
MNPR3
IMB
AST